Drug Type CAR-T |
Synonyms CT RD06 |
Target |
Mechanism CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors), Gene transference, T lymphocyte replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseEarly Phase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-Hodgkin Lymphoma | Phase 1 | CN | 15 Apr 2020 | |
B-Cell Lymphoma | Phase 1 | CN | 05 Feb 2020 | |
Pre B-cell acute lymphoblastic leukemia | Phase 1 | CN | 05 Feb 2020 |